Reva Medical Institute Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 55.54%
(FY 2020)
- Profit 126.93%
(FY 2020)
- Ebitda 371.06%
(FY 2020)
- Net Worth 2.98%
(FY 2020)
- Total Assets 31.95%
(FY 2020)
About Reva Medical Institute
The Corporate was formerly known as Reva Medicare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satya Divi and Ramana Bathi serve as directors at the Company.
- CIN/LLPIN
U85110TG2009PTC063459
- Company No.
063459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Reva Medical Institute Private Limited offer?
Reva Medical Institute Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Skin Treatment Solution.
Who are the key members and board of directors at Reva Medical Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satya Divi  | Director | 28-Apr-2009 | Current |
| Ramana Bathi | Director | 03-Jun-2017 | Current |
Financial Performance and Corporate Structure Insights of Reva Medical Institute.
Reva Medical Institute Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 55.54% increase. The company also saw a substantial improvement in profitability, with a 126.93% increase in profit. The company's net worth moved up by a moderate rise of 2.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reva Medical Institute?
In 2019, Reva Medical Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shuddh Health Care Private LimitedActive 10 years 10 monthsSatya Divi and Ramana Bathi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reva Medical Institute?
Unlock and access historical data on people associated with Reva Medical Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reva Medical Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reva Medical Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
